These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

189 related items for PubMed ID: 36083779

  • 1. Citrullinated fibrinogen forms densely packed clots with decreased permeability.
    Varjú I, Tóth E, Farkas ÁZ, Farkas VJ, Komorowicz E, Feller T, Kiss B, Kellermayer MZ, Szabó L, Wacha A, Bóta A, Longstaff C, Kolev K.
    J Thromb Haemost; 2022 Dec; 20(12):2862-2872. PubMed ID: 36083779
    [Abstract] [Full Text] [Related]

  • 2. Procoagulant changes in fibrin clot structure in patients with cirrhosis are associated with oxidative modifications of fibrinogen.
    Hugenholtz GC, Macrae F, Adelmeijer J, Dulfer S, Porte RJ, Lisman T, Ariëns RA.
    J Thromb Haemost; 2016 May; 14(5):1054-66. PubMed ID: 26833718
    [Abstract] [Full Text] [Related]

  • 3. Citrullination of fibrinogen by peptidylarginine deiminase 2 impairs fibrin clot structure.
    Damiana T, Damgaard D, Sidelmann JJ, Nielsen CH, de Maat MPM, Münster AB, Palarasah Y.
    Clin Chim Acta; 2020 Feb; 501():6-11. PubMed ID: 31730822
    [Abstract] [Full Text] [Related]

  • 4. Structure, Mechanical, and Lytic Stability of Fibrin and Plasma Coagulum Generated by Staphylocoagulase From Staphylococcus aureus.
    Farkas ÁZ, Farkas VJ, Szabó L, Wacha A, Bóta A, Csehi L, Kolev K, Thelwell C.
    Front Immunol; 2019 Feb; 10():2967. PubMed ID: 31921206
    [Abstract] [Full Text] [Related]

  • 5. Recombinant fibrinogen reveals the differential roles of α- and γ-chain cross-linking and molecular heterogeneity in fibrin clot strain-stiffening.
    Piechocka IK, Kurniawan NA, Grimbergen J, Koopman J, Koenderink GH.
    J Thromb Haemost; 2017 May; 15(5):938-949. PubMed ID: 28166607
    [Abstract] [Full Text] [Related]

  • 6. DNA and histones impair the mechanical stability and lytic susceptibility of fibrin formed by staphylocoagulase.
    Komorowicz E, Farkas VJ, Szabó L, Cherrington S, Thelwell C, Kolev K.
    Front Immunol; 2023 May; 14():1233128. PubMed ID: 37662916
    [Abstract] [Full Text] [Related]

  • 7. Interpretation and Validation of Maximum Absorbance Data Obtained from Turbidimetry Analysis of Plasma Clots.
    Pieters M, Guthold M, Nunes CM, de Lange Z.
    Thromb Haemost; 2020 Jan; 120(1):44-54. PubMed ID: 31752041
    [Abstract] [Full Text] [Related]

  • 8. Fibrin clots from patients with acute-on-chronic liver failure are weaker than those from healthy individuals and patients with sepsis without underlying liver disease.
    Driever EG, Muntz I, Patel V, Adelmeijer J, Bernal W, Koenderink GH, Lisman T.
    J Thromb Haemost; 2023 Oct; 21(10):2747-2758. PubMed ID: 37336436
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Automated Fiber Diameter and Porosity Measurements of Plasma Clots in Scanning Electron Microscopy Images.
    Daraei A, Pieters M, Baker SR, de Lange-Loots Z, Siniarski A, Litvinov RI, Veen CSB, de Maat MPM, Weisel JW, Ariëns RAS, Guthold M.
    Biomolecules; 2021 Oct 18; 11(10):. PubMed ID: 34680169
    [Abstract] [Full Text] [Related]

  • 11. Detection of Citrullinated Fibrin in Plasma Clots of Rheumatoid Arthritis Patients and Its Relation to Altered Structural Clot Properties, Disease-Related Inflammation and Prothrombotic Tendency.
    Bezuidenhout JA, Venter C, Roberts TJ, Tarr G, Kell DB, Pretorius E.
    Front Immunol; 2020 Oct 18; 11():577523. PubMed ID: 33424834
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Sensing adhesion forces between erythrocytes and γ' fibrinogen, modulating fibrin clot architecture and function.
    Guedes AF, Carvalho FA, Domingues MM, Macrae FL, McPherson HR, Santos NC, Ariёns RAS.
    Nanomedicine; 2018 Apr 18; 14(3):909-918. PubMed ID: 29410160
    [Abstract] [Full Text] [Related]

  • 14. Fibrin Fiber Stiffness Is Strongly Affected by Fiber Diameter, but Not by Fibrinogen Glycation.
    Li W, Sigley J, Pieters M, Helms CC, Nagaswami C, Weisel JW, Guthold M.
    Biophys J; 2016 Mar 29; 110(6):1400-10. PubMed ID: 27028649
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Whole blood clots are more resistant to lysis than plasma clots--greater efficacy of rivaroxaban.
    Varin R, Mirshahi S, Mirshahi P, Klein C, Jamshedov J, Chidiac J, Perzborn E, Mirshahi M, Soria C, Soria J.
    Thromb Res; 2013 Mar 29; 131(3):e100-9. PubMed ID: 23313382
    [Abstract] [Full Text] [Related]

  • 18. Morphometric characterization of fibrinogen's αC regions and their role in fibrin self-assembly and molecular organization.
    Protopopova AD, Litvinov RI, Galanakis DK, Nagaswami C, Barinov NA, Mukhitov AR, Klinov DV, Weisel JW.
    Nanoscale; 2017 Sep 21; 9(36):13707-13716. PubMed ID: 28884176
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Citrullinated fibrinogen shows defects in FPA and FPB release and fibrin polymerization catalyzed by thrombin.
    Okumura N, Haneishi A, Terasawa F.
    Clin Chim Acta; 2009 Mar 21; 401(1-2):119-23. PubMed ID: 19109936
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.